Risk factors for pulmonary function alterations in children with metabolic dysfunction-associated fatty liver disease

Children with metabolic dysfunction-associated fatty liver disease (MAFLD) may exhibit abnormal lung function. However, it is unclear whether these abnormalities are independent of BMI. Moreover, the specific patterns of abnormal pulmonary function parameters have not been fully characterized, and the risk factors associated with impaired pulmonary function remain insufficiently understood. This study included 40 overweight or obese children with MAFLD and 30 overweight or obese control subjects without MAFLD. Pulmonary function parameters and anthropometric parameters were compared between children with MAFLD and the control group. Additionally, liver function, lipid and glucose metabolism, and cytokine levels were assessed. Multivariable regression analysis was used to identify risk factors for abnormal pulmonary function in children with MAFLD. No significant difference in BMI was observed between the groups (p = 0.075). Pulmonary function tests showed that FVC was significantly higher in children with MAFLD compared to controls (p < 0.001). In contrast, PEF, FEV1/FVC, FEF50, FEF75, and MMEF were lower in the MAFLD group (p < 0.05). Multivariable regression analysis demonstrated that HOMA-IR was significantly and inversely associated with FEF25 (b = -1.51, 95% CI: -2.33 to -0.69, p = 0.001), FEF50 (b = -1.85, 95% CI: -3.01 to -0.70, p = 0.003), and FEF75 (b = -1.44, 95% CI: -2.53 to -0.35, p = 0.01) among children with MAFLD. Furthermore, IL-1β levels were negatively correlated with MMEF (b = -1.16, 95% CI: -2.17 to -0.149, p = 0.03) and FEF50 (b = -0.63, 95% CI: -1.16 to -0.09, p = 0.02). These findings indicate that children aged 8 to 14 years with MAFLD exhibit higher FVC, along with a lower FEV1/FVC ratio and impaired small airway function compared to controls. This impairment in lung function is independent of BMI. Furthermore, HOMA-IR values and elevated IL-1β levels are key risk factors linked to abnormal small airway function.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2025-12-09
DOI
https://doi.org/10.1038/s41598-025-27313-1
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Risk factors for pulmonary function alterations in children with metabolic dysfunction-associated fatty liver disease

Yao Xu, Liqi Yang, Lei Huang, Sen-Mao Xu et al.
Scientific Reports
Liver Disease Diagnosis and Treatment
article

Risk factors for pulmonary function alterations in children with metabolic dysfunction-associated fatty liver disease

Yao Xu, Liqi Yang, Lei Huang, Sen-Mao Xu, Shuqin Wang
article en

Abstract

Children with metabolic dysfunction-associated fatty liver disease (MAFLD) may exhibit abnormal lung function. However, it is unclear whether these abnormalities are independent of BMI. Moreover, the specific patterns of abnormal pulmonary function parameters have not been fully characterized, and the risk factors associated with impaired pulmonary function remain insufficiently understood. This study included 40 overweight or obese children with MAFLD and 30 overweight or obese control subjects without MAFLD. Pulmonary function parameters and anthropometric parameters were compared between children with MAFLD and the control group. Additionally, liver function, lipid and glucose metabolism, and cytokine levels were assessed. Multivariable regression analysis was used to identify risk factors for abnormal pulmonary function in children with MAFLD. No significant difference in BMI was observed between the groups (p = 0.075). Pulmonary function tests showed that FVC was significantly higher in children with MAFLD compared to controls (p < 0.001). In contrast, PEF, FEV1/FVC, FEF50, FEF75, and MMEF were lower in the MAFLD group (p < 0.05). Multivariable regression analysis demonstrated that HOMA-IR was significantly and inversely associated with FEF25 (b = -1.51, 95% CI: -2.33 to -0.69, p = 0.001), FEF50 (b = -1.85, 95% CI: -3.01 to -0.70, p = 0.003), and FEF75 (b = -1.44, 95% CI: -2.53 to -0.35, p = 0.01) among children with MAFLD. Furthermore, IL-1β levels were negatively correlated with MMEF (b = -1.16, 95% CI: -2.17 to -0.149, p = 0.03) and FEF50 (b = -0.63, 95% CI: -1.16 to -0.09, p = 0.02). These findings indicate that children aged 8 to 14 years with MAFLD exhibit higher FVC, along with a lower FEV1/FVC ratio and impaired small airway function compared to controls. This impairment in lung function is independent of BMI. Furthermore, HOMA-IR values and elevated IL-1β levels are key risk factors linked to abnormal small airway function.

Scientific ReportsVol. 15(1)
Anhui Medical University (CN), First Affiliated Hospital of Anhui Medical University (CN), Second Affiliated Hospital of Anhui Medical University (CN), Anhui Mental Health Center (CN)
Anhui Medical University
Openalex Percentile: Top 49%
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.